Company · CIK 0001806310
Taysha Gene Therapies, Inc.
TSHASearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$3.62−$0.11 (−2.95%)
TSHA · Last trade
- Prev close
- $3.73
- Range (29d)
- $3.51 – $5.16
On the record
Recent filings
- SCHEDULE 13G/ATSHATaysha Gene Therapies, Inc.0001231919-26-000928 · 15.6 KBSEC(opens sec.gov)
- SCHEDULE 13G/ATSHATaysha Gene Therapies, Inc.0000895421-26-000269 · 12.0 KBSEC(opens sec.gov)
- 10-QTSHAQuarterly update0001193125-26-344610 · 15.4 MBSEC(opens sec.gov)
- 8-KTSHACurrent report0001193125-26-344594 · 242.3 KBSEC(opens sec.gov)
- 8-KTSHACurrent report0001193125-26-282855 · 541.9 KBSEC(opens sec.gov)
- 8-KTSHACurrent report0001193125-26-276738 · 4.5 MBSEC(opens sec.gov)
- 8-KTSHACurrent report0001193125-26-253478 · 152.7 KBSEC(opens sec.gov)
- 10-QTSHAQuarterly update0001193125-26-207666 · 9.7 MBSEC(opens sec.gov)
- 8-KTSHACurrent report0001193125-26-207633 · 224.6 KBSEC(opens sec.gov)
- 10-KTSHAAnnual report0001193125-26-115202 · 19.9 MBSEC(opens sec.gov)
Insiders
- Alam KamranCHIEF FINANCIAL OFFICER
- Astellas Pharma Inc.10% Owner
- Audentes Therapeutics, Inc.10% Owner
- Donenberg Phillip B.Director
- Long Alison SDirector
- Manning Paul B10% Owner
- Nagendran SukumarDirector, President and Head of R&D
- Nolan Sean P.Director, Chief Executive Officer
- PRASAD SUYASHCMO and Head of R&D
- Reape KathleenDirector
Tickers
Addresses
business
3000 PEGASUS PARK DRIVE SUITE 1430
DALLAS, TX, 75247
mailing
3000 PEGASUS PARK DRIVE SUITE 1430
DALLAS, TX, 75247
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies